HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Ambrož Selected Research

Martin Ambrož Research Topics

Disease

5Neoplasms (Cancer)
02/2018 - 08/2015
3Intestinal Neoplasms (Intestinal Cancer)
11/2017 - 08/2015
2Obesity
10/2021 - 01/2019
1Colorectal Neoplasms (Colorectal Cancer)
04/2019
1Colonic Neoplasms (Colon Cancer)
03/2019
1Non-alcoholic Fatty Liver Disease
01/2019
1Hypercholesterolemia
01/2019
1Breast Neoplasms (Breast Cancer)
11/2017

Drug/Important Bio-Agent (IBA)

4caryophyllene oxideIBA
03/2019 - 08/2015
4SesquiterpenesIBA
03/2019 - 08/2015
4nerolidolIBA
03/2019 - 08/2015
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2017 - 08/2015
3valenceneIBA
03/2019 - 08/2015
3Cytostatic AgentsIBA
03/2019 - 01/2016
3humuleneIBA
03/2019 - 08/2015
3Volatile Oils (Essential Oils)IBA
06/2017 - 08/2015
2MicroRNAs (MicroRNA)IBA
10/2021 - 01/2019
2Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2019 - 03/2019
2Fluorouracil (Carac)FDA LinkGeneric
04/2019 - 03/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2019 - 01/2016
1Glutathione PeroxidaseIBA
10/2021
1CaspasesIBA
04/2019
1Irinotecan (Camptosar)FDA LinkGeneric
04/2019
1OxidesIBA
03/2019
1FructoseIBA
01/2019
1flubendazoleIBA
02/2018
1AntioxidantsIBA
01/2016
1caryophylleneIBA
08/2015

Therapy/Procedure

3Therapeutics
03/2019 - 01/2016